Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Szer

Showing results (161-170 of 195) with videos related to

Pageof 20
Sort By:
Bone Marrow Transplantation|July 1, 1996
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysisM J Styler, P Crilley, J Biggs, et al.
Bone Marrow Transplantation|January 1, 1990
Approaches to blood stem cell mobilisation. Initial Australian clinical resultsC A Juttner, L B To, D N Haylock, et al.
Internal Medicine Journal|August 7, 2015
Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohortA Mallett, P Hughes, J Szer, et al.
British Journal of Haematology|March 2, 1999
Bone marrow transplants for paroxysmal nocturnal haemoglobinuriaR Saso, J Marsh, L Cevreska, et al.
Internal Medicine Journal|April 17, 2004
Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infectionsM A Slavin, J Szer, A P Grigg, et al.
Bone Marrow Transplantation|March 15, 2016
Inadvertent completely HLA-mismatched allogeneic unrelated bone marrow transplant: lessons learnedB S Sorensen, J Szer, B Shaw, et al.
HLA|June 27, 2018
Activating KIR Haplotype Influences Clinical Outcome Following HLA-Matched Sibling Hematopoietic Stem Cell TransplantationS L Heatley, C G Mullighan, K Doherty, et al.
Bone Marrow Transplantation|February 14, 2012
Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trialM H Jagasia, R Abonour, G D Long, et al.
Internal Medicine Journal|June 16, 2016
Changing prognosis in paroxysmal nocturnal haemoglobinuria disease subcategories: an analysis of the International PNH RegistryG Socié, H Schrezenmeier, P Muus, et al.
Blood|September 6, 2001
Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemiaB J Huntly, A G Reid, A J Bench, et al.
Pageof 20

Showing results (161-170 of 195) with videos related to

Sort By:
Pageof 20
Bone Marrow Transplantation|July 1, 1996
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysisM J Styler, P Crilley, J Biggs, et al.
Bone Marrow Transplantation|January 1, 1990
Approaches to blood stem cell mobilisation. Initial Australian clinical resultsC A Juttner, L B To, D N Haylock, et al.
Internal Medicine Journal|August 7, 2015
Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohortA Mallett, P Hughes, J Szer, et al.
British Journal of Haematology|March 2, 1999
Bone marrow transplants for paroxysmal nocturnal haemoglobinuriaR Saso, J Marsh, L Cevreska, et al.
Internal Medicine Journal|April 17, 2004
Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infectionsM A Slavin, J Szer, A P Grigg, et al.
Bone Marrow Transplantation|March 15, 2016
Inadvertent completely HLA-mismatched allogeneic unrelated bone marrow transplant: lessons learnedB S Sorensen, J Szer, B Shaw, et al.
HLA|June 27, 2018
Activating KIR Haplotype Influences Clinical Outcome Following HLA-Matched Sibling Hematopoietic Stem Cell TransplantationS L Heatley, C G Mullighan, K Doherty, et al.
Bone Marrow Transplantation|February 14, 2012
Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trialM H Jagasia, R Abonour, G D Long, et al.
Internal Medicine Journal|June 16, 2016
Changing prognosis in paroxysmal nocturnal haemoglobinuria disease subcategories: an analysis of the International PNH RegistryG Socié, H Schrezenmeier, P Muus, et al.
Blood|September 6, 2001
Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemiaB J Huntly, A G Reid, A J Bench, et al.
Pageof 20